Since hepcidin/iron dysregulation is observed in several hereditary and non-hereditary chronic liver conditions, and hepcidin is recognised as a useful biomarker for liver fibrosis and cirrhosis [8, 24], investigation on iron-induced hepcidin response is of immense clinical value. The gene discussed is HAMP; the disease is Cirrhosis.